Stevens Capital Management’s Globus Medical GMED Stock Holding History

Stevens Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,046	Closed	-$335K	–	313
2024 Q4	$335K	Buy	+4,046	New	+$319K	0.13%	205
2019 Q3	–	Sell	-28,920	Closed	-$1.22M	–	635
2019 Q2	$1.22M	Buy	+28,920	New	+$1.26M	0.05%	333
2019 Q1	–	Sell	-16,442	Closed	-$712K	–	757
2018 Q4	$712K	Buy	+16,442	New	+$820K	0.04%	442
2018 Q2	–	Sell	-8,368	Closed	-$417K	–	853
2018 Q1	$417K	Buy	+8,368	New	+$393K	0.02%	552
2016 Q3	–	Sell	-9,023	Closed	-$215K	–	992
2016 Q2	$215K	Buy	+9,023	New	+$216K	0.01%	759
2015 Q4	–	Sell	-28,504	Closed	-$589K	–	998
2015 Q3	$589K	Buy	28,504 +7,962	+39%	+$202K	0.03%	492
2015 Q2	$527K	Buy	20,542 +11,920	+138%	+$302K	0.02%	604
2015 Q1	$218K	Sell	8,622 -2,205	-20%	-$53.7K	0.01%	837
2014 Q4	$257K	Buy	+10,827	New	+$240K	0.01%	773
2014 Q3	–	Sell	-34,084	Closed	-$815K	–	1091
2014 Q2	$815K	Buy	+34,084	New	+$822K	0.02%	546

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stevens Capital Management's GMED Position: Q1 2025 in Review

Stevens Capital Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 4,046 shares — an estimated $335K sold.

Stevens Capital Management first reported a position in GMED in Q2 2014 and held it in 10 quarters. The position peaked at $1.22M in Q2 2019. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Stevens Capital Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Stevens Capital Management sold 4,046 Globus Medical shares in Q1 2025, an estimated $335K.
Stevens Capital Management first reported a position in Globus Medical in Q2 2014 and held it in 10 quarters.
Stevens Capital Management's Globus Medical position peaked at $1.22M in Q2 2019.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Stevens Capital Management's 13F filing for Q1 2025, filed 7 May 2025.